BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17471453)

  • 1. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers.
    Mijatovic T; Roland I; Van Quaquebeke E; Nilsson B; Mathieu A; Van Vynckt F; Darro F; Blanco G; Facchini V; Kiss R
    J Pathol; 2007 Jun; 212(2):170-9. PubMed ID: 17471453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.
    Uematsu K; He B; You L; Xu Z; McCormick F; Jablons DM
    Oncogene; 2003 Oct; 22(46):7218-21. PubMed ID: 14562050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells.
    Lefranc F; Mijatovic T; Kondo Y; Sauvage S; Roland I; Debeir O; Krstic D; Vasic V; Gailly P; Kondo S; Blanco G; Kiss R
    Neurosurgery; 2008 Jan; 62(1):211-21; discussion 221-2. PubMed ID: 18300910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].
    Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
    Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T; Fujimura M; Kasahara K; Matsuda T
    Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
    Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
    Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy.
    Ishibashi H; Suzuki T; Suzuki S; Niikawa H; Lu L; Miki Y; Moriya T; Hayashi S; Handa M; Kondo T; Sasano H
    Cancer Res; 2005 Jul; 65(14):6450-8. PubMed ID: 16024650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
    Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells.
    Mijatovic T; Jungwirth U; Heffeter P; Hoda MA; Dornetshuber R; Kiss R; Berger W
    Cancer Lett; 2009 Sep; 282(1):30-4. PubMed ID: 19339106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
    Zhang S; Qiu X; Gu Y; Wang E
    Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer.
    Campodónico PB; de Kier Joffé ED; Urtreger AJ; Lauria LS; Lastiri JM; Puricelli LI; Todaro LB
    Mol Carcinog; 2010 Apr; 49(4):386-97. PubMed ID: 20191608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.
    Bartling B; Rehbein G; Schmitt WD; Hofmann HS; Silber RE; Simm A
    Eur J Cancer; 2007 Sep; 43(13):1935-43. PubMed ID: 17689067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.